Cover Image

Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Jingyan Fu, Dan Zhao, Donia Skanji, Hua Liu, Rui (Sammi) Tang, Ying Yuan
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Statistics in Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dual‐Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time‐to‐Event Group Sequential Trials
by: Marco Ratta, et al.
Published: (2026)

Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials
by: Yunyi Liu, et al.
Published: (2026)

A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards
by: Florian Klinglmüller, et al.
Published: (2025)

Analysis of Stepped‐Wedge Cluster Randomized Trials: A Tutorial Using Marginal Models
by: Elizabeth L. Turner, et al.
Published: (2026)

The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints
by: Xinran Huang, et al.
Published: (2024)

Dynamic Borrowing From Historical Controls via the Synthetic Prior With Covariates in Randomized Clinical Trials
by: Daniel E. Schwartz, et al.
Published: (2026)

Bayesian Random‐Effects Meta‐Analysis of Aggregate Data on Clinical Events
by: Christian Röver, et al.
Published: (2026)

Adaptive Designs in Trials With Time‐to‐Event Endpoints and Covariate Adjustment
by: Daniel Backenroth, et al.
Published: (2026)

Model‐Robust Standardization in Cluster‐Randomized Trials
by: Fan Li, et al.
Published: (2025)

Time‐Varying Treatment Effect Models in Stepped‐Wedge Cluster‐Randomized Trials With Multiple Interventions
by: Zhe Chen, et al.
Published: (2026)

Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials
by: Godwin Yung, et al.
Published: (2025)

Semiparametric Estimation of Relative Causal Effects in Randomized Controlled Trials With Noncompliance
by: Wenli Liu, et al.
Published: (2025)

Correction to “Model‐Robust Standardization in Cluster‐Randomized Trials”
Published: (2026)

Network Meta‐Analysis With Individual Participant‐Level Data of Time‐to‐Event Outcomes Using Cox Regression
by: Kaiyuan Hua, et al.
Published: (2025)

A Precision Mixture Risk Model to Identify Adverse Drug Events in Subpopulations Using a Case‐Crossover Design
by: Yi Shi, et al.
Published: (2024)

Dynamic Borrowing With a Bias‐Tolerance Cap in Augmented Randomized Controlled Trials
by: Kota Sawada, et al.
Published: (2026)

A Bayesian Prevalence‐Incidence Mixture Model for Screening Outcomes With Misclassification
by: Thomas Klausch, et al.
Published: (2026)

A Partially Randomized Patient Preference, Sequential, Multiple‐Assignment, Randomized Trial Design Analyzed via Weighted and Replicated Frequentist and Bayesian Methods
by: Marianthie Wank, et al.
Published: (2024)

Modern Causal Inference Approaches to Improve Power for Subgroup Analysis in Randomized Controlled Trials
by: Antonio D'Alessandro, et al.
Published: (2026)

Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule
by: Juhee Lee, et al.
Published: (2024)

Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials
by: Xi Fang, et al.
Published: (2026)

A Framework for Generating Realistic Synthetic Tabular Data in a Randomized Controlled Trial Setting
by: Niki Z. Petrakos, et al.
Published: (2025)

Bayesian Network Meta‐Analysis With One or Two Continuous Outcomes Measured at Multiple Time Points Using Gaussian Random Walks With Drift
by: Pai‐Shan Cheng, et al.
Published: (2026)

A Bayesian Mixture of Exponential Family Factor Models for Uncovering Disease Progression Subtypes
by: Kai Kang, et al.
Published: (2025)

Sample Size Re‐Estimation in Blinded Hybrid‐Control Design Using Inverse Probability Weighting
by: Masahiro Kojima, et al.
Published: (2026)

A Bayesian Location‐Scale Joint Model for Time‐To‐Event and Multivariate Longitudinal Data With Association Based on Within‐Individual Variability
by: Marco Palma, et al.
Published: (2026)

Joint Frailty Mixture Cure Model for Recurrent Event Data With Dependent Censoring: An MCEM Approach
by: Nasrin Sultana, et al.
Published: (2026)

Bayesian Power Prior in Platform Trials With Non‐Concurrent Control for Binary Outcomes: Development and Comparative Evaluation
by: Junichi Asano, et al.
Published: (2026)

Bayesian Calibration of Stochastic Agent Based Model via Random Forest
by: Connor Robertson, et al.
Published: (2025)

Time‐Dependent ROC Curve for Multiple Longitudinal Biomarkers and Its Application in Diagnosing Cardiovascular Events
by: Lizhe Sun, et al.
Published: (2025)

Comments on “Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods”
by: M. C. Donohue, et al.
Published: (2025)

On Anticipation Effect in Stepped Wedge Cluster Randomized Trials
by: Hao Wang, et al.
Published: (2026)

Bayesian Hierarchical Models With Calibrated Mixtures of g‐priors for Assessing Treatment Effect Moderation in Meta‐Analysis
by: Qiao Wang, et al.
Published: (2026)

COMIC: A Bayesian Dose Optimization Design for Drug Combination in Multiple Indications With Application to CAR‐T Therapies
by: Kai Chen, et al.
Published: (2025)

Bayesian Ordered Lattice Design for Phase I Clinical Trials
by: Gi‐Ming Wang, et al.
Published: (2026)

Analysis of Cohort Stepped Wedge Cluster‐Randomized Trials With Nonignorable Dropout via Joint Modeling
by: Alessandro Gasparini, et al.
Published: (2025)

Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials
by: Liwen Wu, et al.
Published: (2025)

Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
by: Jingya Gao, et al.
Published: (2024)

Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials
by: Yuwei Cheng, et al.
Published: (2026)

Response to Letter to the Editor “Comments on ‘Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods’”
by: Guoqiao Wang, et al.
Published: (2025)